GSK-3β Profiling for Early GVHD Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing Graft-versus-Host Disease (GVHD) are invasive, time-consuming, and unreliable, often only detecting T-cell proliferation after clinical symptoms appear, leading to delayed and inaccurate diagnosis and treatment.
Innovation Solution
A method involving the measurement and profiling of GSK-3β activation and expression levels, along with related pathways, to detect T-cell proliferation early, using techniques such as protein chip technology and fingerprinting methods, allowing for non-invasive diagnosis before symptom onset.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If biopsy procedures are used to diagnose GVHD, then diagnostic accuracy is improved, but the procedure becomes invasive and time-consuming with delays of 24 to 48 hours before diagnosis can be rendered
Solution Approach 1:
The invention measures GSK-3β activation status and related pathway parameters in blood samples to detect T-cell proliferation before clinical symptoms appear. This preliminary detection allows diagnosis to be made earlier than with biopsy, reducing the time delay while maintaining diagnostic accuracy through molecular markers that indicate impending tissue damage
Solution Approach 2:
The invention uses GSK-3β activation status and related pathway molecules as intermediary markers that reflect the underlying pathological process of T-cell proliferation. These molecular intermediaries provide diagnostic information without requiring direct tissue sampling, thus reducing invasion and time delay while preserving diagnostic reliability
2Reliability
If biopsy procedures are used to procure tissue for diagnosis, then diagnostic information is obtained, but the procedure is invasive to the patient
Solution Approach 1:
The invention uses circulating molecular markers (GSK-3β activation status, phosphorylation levels, and related pathway molecules) in blood samples as intermediaries that reflect the pathological state without requiring direct tissue sampling. This provides diagnostic information while avoiding the invasiveness of biopsy procedures
Solution Approach 2:
The invention replaces the mechanical tissue sampling process of biopsy with molecular analysis of blood samples. Instead of physically extracting tissue, the method uses biochemical assays to detect pathway activation status, substituting a less invasive analytical approach for the invasive mechanical procedure
3Reliability
If diagnosis is determined only after T cells are already attacking host tissues and clinical symptoms are apparent, then observable disease manifestations are detected, but treatment opportunities are lost and morbidity increases
Solution Approach 1:
The invention performs preliminary detection of T-cell proliferation by measuring GSK-3β activation status and related pathway molecules before clinical symptoms develop. This early detection enables intervention during the subclinical phase, preventing progression to overt disease and reducing morbidity
Solution Approach 2:
The invention establishes a feedback mechanism by continuously monitoring GSK-3β activation status and related pathway parameters in blood samples. This allows dynamic assessment of T-cell proliferation activity and enables timely adjustment of treatment to prevent disease progression before clinical symptoms appear
Data Source
AI summary
The present invention discloses a method of detecting T-cell proliferation in a subject comprising the steps of (a) obtaining a sample from said subject; and (b) profiling at least one parameter selected from the group consisting of: the activation level of GSK-3β, the expression level of GSK-3β and the activation or expression level of related members of pathways in which GSK-3β plays a part. It is a core aspect of the invention, wherein a significant deviation from normal values indicates cellular proliferation. The present invention further discloses kits for detecting T-cell proliferation.